Cipla stays sideways as global policy risks loomTopic Statement:
Cipla has remained stuck in a sideways range for months, with potential downside pressure emerging from shifting global policies.
Key Points:
1. The stock has been hovering around the 23.6% Fibonacci retracement level at 1502, influenced by both national and global economic factors
0.8 USD
623.62 M USD
3.25 B USD
About Cipla Ltd
Sector
Industry
CEO
Umang Vohra
Website
Headquarters
Mumbai
Founded
1935
ISIN
US1729772095
FIGI
BBG000Q4YY55
Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.
Related stocks
CIPLA (Weekly Timeframe) - Can it breakout ??Cipla has been in an accumulation stage for a while. Few attempts to breakout of the 1600 zone has not been successful. With EMAs in positive cross-over state, the stock looks to breakout of this key resistance zone. The volume is also OK in the past few weeks.
To be monitored on how it goes in the
U.S. Inhaler Play and Strong Earnings Fuel Long-Term UpsideTicker: NSE: CIPLA
Sector: Pharmaceuticals
Market Cap: ₹1.26 lakh crore+
Current Price: ₹1,572 (as of July 28, 2025)
Technical Rating: ⭐⭐⭐⭐⭐ (Strong Buy across platforms)
________________________________________________________________________________
🔍 Strong Fundamentals Back the Bullish Momentum
CIPLA: Darvas Box Breakout Post Results ReactionNSE:CIPLA Darvas Box Breakout Post Q1 FY 26 Results Reaction: Why This Pharma Giant Could Be Your Next Big Winner Let's Analyze
Price Action:
Price Movement Characteristics:
- Volatility: Compressed volatility within the Darvas Box range
- Price Swings: Controlled swings between ₹1,480-1,532.50
Cipla Trades Sideways Within Defined Range, Eyes Possible DoubleTopic Statement:
Cipla is currently stuck in a sideways zone, consolidating between key retracement levels while setting up for a potential move higher.
Key Points:
* The price is moving between 1502 (23.6% retracement) and 1380 (38.2% retracement), forming a clear horizontal range
* It remains fai
CIPLASTits difficult to write like the depth of analysis, not a writer !!). I think large scale distribution has happened post july 24. strong bearish reversal like engulfing, evening star & hanging mans on weekly timeframe, hammer low broken multiple times and head & shoulder with wounded neckline; MACD h
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
2520
NEXT FUNDS Emerging Market Equity MSCI-EM (Unhedged) Exchange Traded Fund UnitsWeight
0.10%
Market value
21.49 K
USD
Explore more ETFs